BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8767657)

  • 1. [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma].
    Kleinhans M; Schmid-Grendelmeier P; Burg G
    Hautarzt; 1996 Jun; 47(6):432-7. PubMed ID: 8767657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant melanoma and levodopa in Parkinson's disease: causality or coincidence?
    Fiala KH; Whetteckey J; Manyam BV
    Parkinsonism Relat Disord; 2003 Aug; 9(6):321-7. PubMed ID: 12853231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma and levodopa: is there a relationship? Two new cases and a review of the literature.
    Pfützner W; Przybilla B
    J Am Acad Dermatol; 1997 Aug; 37(2 Pt 2):332-6. PubMed ID: 9270541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature.
    Kochar AS
    Am J Med; 1985 Jul; 79(1):119-21. PubMed ID: 4014296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levodopa therapy and the risk of malignant melanoma.
    Siple JF; Schneider DC; Wanlass WA; Rosenblatt BK
    Ann Pharmacother; 2000 Mar; 34(3):382-5. PubMed ID: 10917387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of long-term levodopa therapy in malignant melanoma.
    Woofter MJ; Manyam BV
    Clin Neuropharmacol; 1994 Aug; 17(4):315-9. PubMed ID: 9316678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanoma and levodopa.
    Rampen F
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):782-4. PubMed ID: 9591833
    [No Abstract]   [Full Text] [Related]  

  • 8. Melanoma, Parkinson's disease and levodopa: causal or spurious link? A review of the literature.
    Zanetti R; Loria D; Rosso S
    Melanoma Res; 2006 Jun; 16(3):201-6. PubMed ID: 16718266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Melanoma while using levodopa due to Parkinson's disease--causal association unlikely].
    Wobbes T; Bonenkamp JJ
    Ned Tijdschr Geneeskd; 2002 Jul; 146(27):1286-8. PubMed ID: 12138675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa and the risk of melanoma.
    Zanetti R; Rosso S
    Lancet; 2007 Jan; 369(9558):257-8. PubMed ID: 17258651
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment with levodopa and risk for malignant melanoma.
    Olsen JH; Tangerud K; Wermuth L; Frederiksen K; Friis S
    Mov Disord; 2007 Jul; 22(9):1252-7. PubMed ID: 17534943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa, melanoma, and Parkinson's disease.
    Weiner WJ; Singer C; Sanchez-Ramos JR; Goldenberg JN
    Neurology; 1993 Apr; 43(4):674-7. PubMed ID: 8469320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant melanoma and L-dopa. Review of literature on the problem of causal relationship].
    Happle
    Fortschr Med; 1974 Sep; 92(27):1065-6. PubMed ID: 4457419
    [No Abstract]   [Full Text] [Related]  

  • 14. Levodopa and melanoma: three cases and review of literature.
    Rampen FH
    J Neurol Neurosurg Psychiatry; 1985 Jun; 48(6):585-8. PubMed ID: 4009196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levodopa therapy and malignant melanoma.
    Sober AJ; Wick MM
    JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant melanoma in early Parkinson's disease: the DATATOP trial.
    Constantinescu R; Romer M; Kieburtz K;
    Mov Disord; 2007 Apr; 22(5):720-2. PubMed ID: 17373726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease, melanoma, and levodopa.
    Fermaglich J; Delaney P
    J Neurol; 1977 Jun; 215(3):221-4. PubMed ID: 69691
    [No Abstract]   [Full Text] [Related]  

  • 18. Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach.
    Bougea A; Spantideas N; Katoulis A; Stefanis L
    Acta Neurol Belg; 2019 Sep; 119(3):325-336. PubMed ID: 31338806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease, levodopa-use and the risk of melanoma.
    Vermeij JD; Winogrodzka A; Trip J; Weber WE
    Parkinsonism Relat Disord; 2009 Sep; 15(8):551-3. PubMed ID: 19501540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant melanoma and levodopa.
    Rosin MA; Braun M
    Cutis; 1984 Jun; 33(6):572-4. PubMed ID: 6744949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.